Assessment of accuracy and precision of 99mTc-HEPIDA clearances determined by means of a simplified method by Surma, Marian J.
14
Nuclear Medicine Review 2009
Vol. 12, No. 1, pp. 14–22
Copyright © 2009 Via Medica
ISSN 1506–9680
Clinical
nuclear
medicine
Marian J. Surma
Nuclear Medicine Department, Medical University of Łódź, Poland
[Received 6 VI 2009; Accepted 12 VI 2009]
Abstract
BACKGROUND: The aim of the present study was the assess-
ment of the accuracy and precision of our own simplified me-
thod for the determination of 99mTc-HEPIDA liver clearance.
MATERIAL AND METHODS: It has been assumed that archived
results of plasma clearance (ClPl) and hepatic (ClHp), determined
by means of multisample methods, could be legitimately used
as a reference standard.
The accuracy and precision of the simplified method was
assessed by means of a Monte Carlo method alternatively uti-
lizing three blood sampling times (T) of 68, 75 and 83 minutes
post i.v. administration of 99mTc-HEPIDA. The corresponding
alternative three urine voiding times (Y) were: 75, 80, and
95 min p.i.
The analysed model was created accepting values of ClPl and
ClHp, of administered activity Ap and parameters of biexponential
function, describing the concentration C(t) decrease of the ra-
diopharmaceutical (RF) in plasma during time as real values.
Using the function C(t) for each individual, the plasma concen-
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trations of RF at three sampling times, urinary clearance
(ClPl – ClHp), and voided activity (AUr(Y)) were calculated.
Simulated random errors were added to the assumed blood
sampling times T and to voiding time Y. To the activity Ap and
AUr(Y), and RF plasma concentrations random errors were
added, assuming normal distribution with relative SD from 0 to
5% and then clearance values were computed. For each pro-
cess there were 5000 repeated simulated determinations.
The accuracy of the simplified methods was assessed by com-
paring mean values of simulated clearance computations with
the reference. Comparison of standard deviations with mean un-
certainties enabled us to gain insight into the degree of agree-
ment of the estimator of relative uncertainty with the coefficient
of variation as a measure of precision.
RESULTS: There were strong correlations between the refe-
rence clearance values and the mean values of determinations
by means of the simplified procedure (r > 0.93). The correla-
tions were practically insensitive to the uncertainty of pipet-
ting. The lines of regression differed slightly from the lines of
identity, giving an indication that there was a systematic error
involved; it amounted to +4 ml/min at ClPl = 60 ml/min and to
–7 ml/min for ClPl of 370 ml/min. For ClHp a bias of +6 ml/min
was found for a clearance value of 16 ml/min and –13 ml/min
at ClHp > 300 ml/min.
At uncertainty of pipetting of 2%, a precision of 6–7% was found
for ClPl of 300 ml/min. For ClPl of 200 and 150 ml/min the corre-
sponding precisions were 7–8% and 10%, respectively.
For ClHp of 200, 150 and 100 ml/min the corresponding preci-
sions were 10, 12 and 17%, respectively. These precisions are
5 percent worse than those that were obtained from determina-
tions by means of multisampling procedures.
Key words: hepatic 99mTc-HEPIDA clearance error, hepatic
99mTc-HEPIDA clearance determination
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Introduction
The determination of plasma clearance (ClPl) and hepatic clear-
ance (ClHp) of 
99mTc-HEPIDA (dimethyl-acetanilide-iminodiacetic
acid) by multisampling method is an efficacious overall procedure
for evaluation of liver parenchyma damage [1–3]. The analysis of
the metrological characteristics demonstrated that determination
of the clearances by multisample methods proved to be very ac-
curate and precise [4].
In the Nuclear Medicine Department of the Medical Universi-
ty of Lodz, a new simplified method for the determination of
99mTc-HEPIDA plasma clearance and hepatic clearance was elab-
orated [5,6]. The method requires withdrawing one blood sam-
ple at predefined time post iv. injection of 99mTc-HEPIDA and for
hepatic clearance additional determination of activity excreted
with urine. The clinical value of the simplified 99mTc-HEPIDA clear-
ances has been positively assessed [7]. However, using these
simplified methods raises questions concerning the metrologi-
cal characteristics and, in particular, calls for evaluation of their
precision and accuracy.
The aims of the studies
The principal aim of the study was the assessment of the ba-
sic metrological characteristics of the accuracy and precision
of the determination of 99mTc-HEPIDA plasma (ClPl) and hepatic
clearance (ClHp) by a simplified method and the investigation into
how some factors, which should be seen as potential sources of
errors, affect these characteristics. Additionally, another objec-
tive of these studies was to select a proper estimator of precision
of the clearances.
Theoretical basis
In a simplified method, as in the multisampling one, hepatic clea-
rance ClHp of 
99mTc-HEPIDA is understood as the difference between
two clearances: the  plasma clearance (ClPl) and renal clearance
ClUr. A simplified method for determination of plasma clearance (ClPl)
is based on the experimentally developed equation [6]:
   (1)
where: T is the time at which a single blood sample is obtained
in the range from 63 to 83 min (optimally at 75 min post injection);
where: Ap is the activity injected i.v. to a patient, and C(T) is the
pharmaceutical plasma concentration at time T.
To determine the renal clearance one should know: a) the ac-
tivity eliminated with the urine AUr(Y) from the injection to time Y, at
which urinary bladder emptying takes place, and b) the integral S
in the same time period of the bi-exponential curve C(t) (t signifies
the continuous  flow of time), which describes the changes of the
radiopharmaceutical concentration in the plasma. The activity AUr(Y)
collected at time Y in urine can be directly measured. The integral
(S) of C(t) from 0 to Y, as it has been demonstrated [5, 6], is related
linearly (equation 2) to the radiopharmaceutical concentration C(T)
in blood plasma sampled at T:
    (2)
The parameters H and G depend on the moment of blood sam-
pling at T and the moment of the urinary bladder emptying Y, and
can be calculated from the following equations:
    (3)
     (4)
As can be seen, the plasma concentration C(T) at sampling
time T, together with the activity given to the patient (Ap), is used for
the determination of plasma clearance. Furthermore, it is also used
for determination of the integral S, which together with the activity
AUr (Y) leads to the renal clearance ClUr, which is needed for deter-
mination of ClHp.
In the case of the determination of 99mTc-HEPIDA clearances,
there are a few factors which could affect the error of the measure-
ment. They are the following:
1. The statistical character of the dependencies shown in equa-
tions in (1), (2), (3) and (4) causes an incidental prediction
error with a normal distribution, and the value of which can be
given by the standard error of estimation (SEE). In case of
plasma clearance the error varies from 14.4 to 14.6 ml/min; in
the case of hepatic clearance (ClHp), evaluation of the error is
more complicated, but possible [6].
2. The procedure of pipetting. Uncertainty here is usually of 2%.
However, this value may change in a wider bracket even up to
5%.
3. Blood sampling time measurement and the moment of uri-
nary bladder emptying. Blood samples are taken usually at
established times after the injection but the whole process
takes about 5 seconds. There are, however, cases in which
blood sampling process lasts as long as 1 minute, so one
might wish to know when the process has begun and when it
has ended. Similarly, urinary bladder emptying takes up to 5
minutes.
4. The stochastic character of radioactive decay. This error is de-
fined according to a Poisson distribution and is controlled in such
a way that the precision of the results is not worse than 1%.
These factors overlap each other and lead to the fact that the
final result of the determination of clearances is burdened with
an error, which could be directly assessed by repeated measure-
ments of the given quantity. However, in the case of clearance
determination, this is impossible. For this reason the analysis of
metrological characteristics requires the use of Monte Carlo meth-
ods.
For estimation of the accuracy of clearance measurements,
a multisampling Monte Carlo method was used, based on the sim-
ulation of respective determinations, and metrological character-
istics were obtained. The present study presents the results of the
same method for the evaluation of a simplified procedure for clea-
rance determination.
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Material and methods
To establish a model for accuracy and precision assessment,
the archive results of 172 patients of hepatic (ClHp ) 
99mTc-HEPIDA
clearances were taken. The clearances were determined by
a multisampling method and they, as really true, served as refe-
rence values. Plasma clearance values ranged from 64 ml/min to
365 ml/min: the hepatic clearances ranged from 16 ml/min to
306 ml/min. There were also given values of activities Ap admini-
stered, and the parameters of bi-exponential function C(t) de-
scribing the changes of radiopharmaceutical concentration in the
plasma vs. time. It was assumed that these data show real va-
lues and real processes of concentration decay. The data from
the patients' records allowed the calculation of real values of ra-
diopharmaceutical concentration in the plasma at three moments
of time T 68 min, 75 min, and 83 min, p.i. It was also possible to
calculate the real value of the activity eliminated with urine AUr(Y),
accumulated up to time Y, taken respectively as 75 min, 80 min
and 95 min after iv. administration of the radiopharmaceutical.
Simulation of measured values
Time measurements
Random values of rectangular distribution were added to the
above-mentioned values of sampling time T and to time of bladder
empting Y. Half of range of distribution DT assumed values of 0 s,
2.5 s, 5.0 s, 10 s, 20 s, and DY range assumed values of 0 min,
3 min and 6 min. The concentration of radiopharmaceutical in plas-
ma samples were calculated from the function varied at moments
C(T + e), –DT £ e £ DT. However it has been assumed that the
sampling took place at an undisturbed moment of time T. The de-
termination of activity eliminated with the urine was treated similarly.
Pipetting procedure
Three random values of normal distribution representing three
independent activity measurements were added to real values of Ap
and AUr. To the established (calculated above) radiopharmaceutical
concentration in plasma, a random value from the normal distribu-
tion was added — it corresponded to the error caused by pipetting
during the preparation of one plasma sample. Relative standard
deviations of normal distribution were 0%, 1%, 2%, 3%, 4%, and 5%
which corresponded to relative fluctuations of pipetting. From three
measured values of given activity Ap and of AUr mean values and
standard deviations were calculated, which were used for compu-
ting the clearances and uncertainty of the measurements.
Stochastic character of radioactive decay
To the previously calculated (modified) activity values of Ap and
AUr(Y) as well as plasma concentration values, random errors of
normal distribution were added with 1% relative standard devia-
tion, which corresponded to errors caused by the stochastic cha-
racter of radioactive decay and measurements of samples with
a precision not worse than 1%.
The prediction of regression
The obtained values Ap and AUr(Y) and C(T) were put into the
equations (1), (2), (3), and (4) and values of clearances were calcu-
lated. Random values of normal distribution within standard error
of estimation (SEE ª 14.5 ml/min) were added to the calculated
values.
Multiplicity of simulations
For each individual, 5000 clearance simulation determinations
were carried out obtaining each time the values of both clearances
and superposition standard deviation (computed on the basis of
a total differential) (SSD) i.e. a standard deviation computed in ac-
cord with the superposition law. The obtained 5000 values allowed
further the determinaion of:
1. Mean clearances values of ClPl and ClHp.
2. Root mean square (RMS) errors of both clearances.
3. Standard deviations (SD) computed from 5000 values of clea-
rances.
4. Mean SDD values.
Assessment of accuracy
To evaluate proper accuracy of measurement, mean values of
ClPl and ClHp were correlated with reference values (see “Material
and methods”), and the obtained line of regression compared with
the identity line. As tools of evaluation, the following indicators were
used: coefficient of determination R2, standard error of estimation
(SEE), and the distance of regression line from the identity line for
the minimum (D16) and maximum clearance values (D306). These
parameters of R2, SEE, and both distances were defined as agree-
ment indicators. The units of the parameters, with the exception of
R2, is ml/min.
Assessment of precision
For assessment of precision, coefficients of variation were ta-
ken. The latter were used for analyzing changes caused by varying
the factors which contributed to these errors.
The choice of the estimator of uncertainty of a single clearance
determination
To select a proper measure for the estimation of uncertainty of
a single clearance determination the mean values of SDD were
compared with the standard deviations (SD) and the root mean
square errors (RMS) of the given clearances values.
Results
The results presented have been obtained for ClHp and for con-
ditions most often prevailing during routine clinical work, namely T
= 75 min, Y = 80min, DT = 2.5 s, DY = 3min, and Dp/p = 2%.
Accuracy
Figure 1 presents the correlation with the regression line be-
tween the real plasma clearance and mean values taken from
the simulated determinations obtained by the simplified me-
thod. Figure 2 shows similarly the correlation with the regression
line between real values of ClHp and its mean values from simu-
lated determinations, and comparison with the identity line. As
can be seen, both correlations are very close (of which the corre-
lation for ClPl is more close). However, the regression lines inter-
sect with the lines of identity, which indicates that low clearance
values, determined by the simplified method, are overestimated
and its high values are underestimated. Such a discrepancy be-
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Table 2 shows values of agreement indicators for lines of re-
gression with lines of identity for hepatic clearances when varying
the uncertainty of the pipetting process. These data indicate that
uncertainty of pipetting does not influence the general accuracy of
hepatic clearance determination.
Table 3 shows the assembled indicators of agreement of re-
gression lines with lines of identity for hepatic clearances ClHp ob-
tained by the simplified method at varied uncertainty of time at
which the blood sampling had been taken. It can be seen that, the
uncertainty of DT does not practically change the accuracy of ClHp
determination.
Table 4 shows the assembled indicators of agreement of re-
gression between real values and mean values from simulated
determinations at varied moments of time for blood sampling (T)
and urinary bladder voiding (Y), and uncertainty DY of time at which
urinary bladder voiding took place. As can be seen from the table
the correlation between the time for blood sampling and bladder
voiding is accurate, but there is a greater discrepancy between
the line of identity and the line of regression. However, the uncer-
tainty of time measurement at which urine bladder voiding took
place, does not affect the accuracy of determination.
Precision
Figure 3 shows the changes of root mean square (RMS) error
and of standard deviation as a function of the value of hepatic 99mTc-
-HEPIDA clearance ClHp, when determined by the simplified meth-
od. It follows from the graph that standard deviation of ClHp is in
good agreement with the corresponding values of mean square
errors. For some clearance determinations, however, values of
square errors are larger than the standard deviations. This could
be due to a systematic error. There are similar relations between
mean square errors and mean values of SSD.
Figure 4 shows how the coefficient of variation and the relative
mean of SSD changes with hepatic clearance value. It can be clearly
seen that both quantities could be used as error estimators.
Figure 5 shows, how the coefficient of variation for four clear-
ance values changes when the pipetting is performed with varying
relative uncertainty. The Figure 5 demonstrates — as expected
— that if the uncertainty of pipetting is increasing, the precision of
hepatic 99mTc-HEPIDA clearance determination (ClHp) is deteriorat-
ing. Such changes are particularly clear for small values of the clear-
ances.
Figure 6 shows the coefficients of variation for the same hepat-
ic clearances at varied uncertainty of the time for blood sampling
DT (for T = 75). It can be clearly seen that the uncertainty of blood
sampling time does not materially affect the uncertainty of hepatic
clearance determination.
Table 5 presents the assembled values of coefficients of varia-
tion for four hepatic clearances obtained by the simplified method
assuming that blood was taken at T = 75min and the bladder was
emptied at Y = 80 min at varied uncertainty of bladder voiding
time.
In Table 6 again there are assembled values of the coefficient
of variations for the same four hepatic clearances versus varied
moments of blood sampling time and at different moments of urine
voiding time Y (uncertainty DT = 2.5 s and DY=3min, respectively).
As can be clearly seen, the uncertainty of time measure DY does
Figure 2. Correlation of real clearance of ClHp and mean values of simulated
determination by the simplified method.
Figure 1. The correlation of real clearances of ClPl and mean values
of simulated determination by the simplified method.
tween these lines is more clearly visible for the hepatic than for
the plasma clearances.
Table 1 shows assembled the values of agreement indicators
of regression lines with the identity line for hepatic clearances;
the moment the blood sampling is taken at three different times
p.i. and bladder voiding process takes place later. It seems clear
that the moment of blood sampling does not influence the change
of these indicators. However, it can be seen, that the later the
blood sampling and bladder voiding takes place, the more clear-
ly apparent the discrepancy between the line of identity and the
regression line.
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not practically affect the precision of the hepatic clearance deter-
mination.
Discussion
Determination of clearances, mostly renal, using isotope tech-
niques has been known for decades. The theoretical foundations
of these methods as based upon a single intravenous injection of
non radioactive compounds and few blood samplings, has been
given by Sapirstein [8]. There are simplified methods for the deter-
mination of renal clearances, which require a single injection of the
radiopharmaceutical and single blood sample [9–12]. Regardless
of the good theoretical foundations of such procedures, very few
studies have been devoted to their metrological characteristics and,
in particular, to their accuracy and precision.
These characteristics for the determination of hepatic 99mTc-
-HEPIDA clearance (ClHp) have been previously analysed when mul-
tisampling methods were used. Applying a simplified method for
the determination of hepatic 99mTc-HEPIDA clearance (ClHp) and
an examination of its usefulness for the assessment of liver func-
tion lead to the conclusion that investigation of the precision and
accuracy is vital.
Table 1. The values of agreement indicators of the regression line and the identity line for hepatic clearances obtained at different moments of
time of blood sampling and bladder voiding
Agreement indicators Value of indicators for different T [min] and Y [min]
T = 68; Y= 75 T = 75; Y = 80 T = 83; Y = 90
R2 0.9674 0.9719 0.9727
SEE 9.99 9.22 9.03
D16 5.98 6.19 6.72
D306 –11.9 –12.7 –13.9
Table 2. Values of agreement indicators for regression line with the identity line for hepatic clearances versus uncertainty of pipetting
Agreement indicators   Values of indicators of agreement for different relative uncertainty of pipetting (%)
0 1 2 3 4 5
R2 0.9718 0.9722 0.9719 0.9716 0.9716 0.9717
SEE 9.24 9.25 9.22 9.27 9.18 9.18
D16 6.12 6.20 6.19 6.19 6.22 6.18
D306 –12.76 –12.71 –12.67 –12.67 –12.56 –12.48
Table 3. Values of agreement indicators for the regression line with the identity line for hepatic clearances as obtained at varied uncertainty
of blood sampling time DT
Agreement indicators                                           Values of indicators of agreement obtained at several uncertainties of sampling time DT [s]
0 2.5 5.0 10.0 20.0
R2 0.9718 0.9717 0.9715 0.9718 0.9716
SEE 9.24 9.22 9.29 9.24 9.26
D16 6.24 6.19 6.23 6.14 6.26
D306 –12.75 –12.67 –12.80 –12.66 –12.75
Table 4. Values of agreement indicators for regression line with the identity line for hepatic clearances at different blood sampling times
T [min], and bladder voiding Y [min], and varied uncertainty of bladder voiding time DY
Agreement parameter Values of indicators of agreement for several T [min] and Y [min]
and  varied uncertainty of bladder emptying time DY [min]
T = 68; Y= 75 T = 75; Y = 80 T = 83; Y = 95
DY = 0 DY = 3 DY = 6 DY = 0 DY = 3 DY=6 DY = 0 DY = 3 DY = 6
R2 0.9675 0.9674 0.9674 0.9708 0.9716 0.9715 0.9729 0.9727 0.9731
SEE 9.95 9.99 9.99 9.26 9.26 9.29 9.00 9.03 8.96
D16 6.01 5.98 5.99 6.20 6.26 6.21 6.67 6.72 6.66
D306 –11.97 –11.90 –11.82 –12.74 –12.75 –12.67 –13.87 –13.90 –13.8
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Figure 3. Root mean square error and standard deviation depending on
the value of hepatic clearance. RMS — root mean square error; SD — stan-
dard deviation.
Figure 4. Coefficient of variation and relative mean SSD depending
on the determined value of ClHp. SSD — superposition standard deviation.
Accuracy
The results obtained from the simulation based on the model
outlined above, demonstrate that mean values of 5000 virtual deter-
mination of the same clearance correlate very highly with the real
values. However, from inspection of Figures 1 and 2 it can be seen
that the regression lines do not coincide completely with the lines of
identity. This might indicate that the determined values are biased.
When the blood sample is taken at 75 min, the obtained values of
plasma clearance (below 175 ml/min) are systematically overesti-
Figure 5. The changes of coefficient of variation for four values of ClHp
depending on uncertainty of pipetting.
Figure 6. The changes of coefficient of variation for four values of ClHp
depending on the moment of blood sampling.
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mated by 4 ml/min, while high values (above 200 ml/min) are sys-
tematically underestimated by approximately 9 ml/min. Low values
of hepatic clearances (below 110 ml/min) are overestimated (up to
6 ml/min), whereas values higher than 110 ml/min are underestimat-
ed (up to13 ml/min). When blood is taken at 83 min both systematic
errors increase to 6.7 ml/min and 14 ml/min, respectively (Table 1).
Similar changes are seen for the determination of the plasma clear-
ances. Analysis of covariance enabled the derivations of a formula
providing a value for the systematic error (e) for each individual clear-
ance and for the optional moment of blood sampling ranging from
68 to 83 min.
The equations are as follows:
a) for the plasma clearance:
b) for the hepatic clearance:
As follows from the subsequent tables, the systematic errors
do not follow the relative uncertainty of pipetting (Table 2), the un-
certainty of blood sampling measures (Table 3), or the uncertainty
of urinary bladder voiding (Table 4).
Precision
The distribution of results of measurements, which are respon-
sible for an imprecise determination, results from the interference
of incidental errors. Precision, as a measure of agreement of re-
sults, is measured by the coefficient of variation, which is a quo-
tient of standard deviation: mean value. The presented model
makes it possible to find a standard deviation and mean value out
of 5000 results, and therefore the coefficient of variation, and to
estimate the importance of the sources of variation. This study also
enabled the comparison of the standard deviation with the root
mean square (RMS) errors, and thus to decide which quantity
should be taken as an overall uncertainty of hepatic or plasma clea-
rance determination.
As Figure 3 shows, for the overwhelming majority of ClHp va-
lues the standard deviations are practically identical to the values
of respective RMS errors; however, for individual values of ClHp there
are some differences which reach as much as 20 ml/min. Similar
observations apply to RMS error and the standard deviation for
plasma clearance. This small difference between RMS errors and
standard deviations is probably due to small systematic errors,
which are not incorporated into the standard deviation. Values of
the coefficients of variation (CV) obtained for various values of the
ClHp in conditions typical for routine analytical work while deter-
mining the uncertainty determination are presented in Figure 4.
A similar variation of CV was seen for ClPl, and — as anticipated
— the values of coefficient of variations for both clearances de-
cline with the absolute value. The CV for ClHp and ClPl above 200
ml/min and 150 ml/min, respectively, do not change significantly,
ranging from 12% to 10%. The precision becomes worse at low
clearance values, and the resulting uncertainty may, to some ex-
tent, jeopardize the unambiguous classification of patients with
ClHp around 80 ml/min. At lower values of ClHp irrespective of the
absence of good overall precision, there is no real problem of in-
terpretation that liver parenchyma performance is a poor one.
The results of further studies make it clear that the coefficient of
variation rises with the increasing uncertainty of pipetting and this
observation applies to low values of both ClHp and ClPl (Figure 5).
When uncertainty of pipetting rose from 1 to 5%, the coefficient of
Table 5. Values of coefficients of variation [%] of four hepatic clearances determined by a simplified method, versus uncertainty of bladder
voiding time [min]
Hepatic clearance [ml/min] Values of variability coefficient [%] for four ClHp at three uncertainties
of bladder voiding DY [min]
0 3 6
23 67.9 67.3 67.2
110 15.9 15.9 15.9
216 12.6 12.6 12.8
293 7.6 7.6 7.6
Table 6. Values of coefficients of variation [%] of the four hepatic clearances determined by a simplified method and assuming three blood
sampling and corresponding bladder voiding times
Hepatic clearance [ml/min] Values of variability coefficient [%] for four ClHp at several blood sampling T [min]
and bladder voiding Y [min] times
T = 68; Y = 75 T = 75; Y = 80 T = 83; Y = 95
23 70.5 67.3 65.7
110 16.1 15.9 16.2
216 12.3 12.6 13.0
293 7.5 7.6 7.8
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variation for plasma clearance of 70 ml/min and hepatic clearance
ClHp = 22 ml/min increased from 68% to 75%, respectively. For
ClPl  = 366 ml/min and ClHp = 306 ml/min the coefficient of varia-
tion increased only from 8% to 12%.
As shown in the following tables and figures the timing preci-
sion of blood sampling and urinary bladder voiding does not affect
the precision of the determination.
To summarize, the coefficient of variation is a good measure of
precision and uncertainty of a single determination, based on the
law of error propagation, and as was shown above, the applied
model allowed the comparison of the standard deviation with
a mean value of superpositional standard deviation (SDD).
Figure 4 shows that within the whole range of ClHp the relative
mean of SSD is identical to the coefficient of variation. Similar ob-
servations are seen for ClPl. This allows, therefore, the replacement
of the customary standard deviation with the superpositional un-
certainty and the use this measure for the evaluation of precision.
To assess fully the precision of the simplified procedure for
ClPl, and ClHp measurement, one should compare the latter with
the precision of a standard multisample method. Such a compa-
rison has been shown in Figures 7 and 8. The uncertainty of clea-
rance determined according to the law of superposition of errors
was taken as a precision for both methods.
Values of precision from the multisampling method were ta-
ken from the previous studies [4]. It can be seen that hepatic
clearance determined by both methods is less precise than over-
all plasma clearance, and the results of a simplified method for
both clearances are from two to five times less precise than those
obtained by the multisampling method. However, it is interesting
to note that for a simplified method there is a clear dependence
of precision upon the determined clearance value, while for the
multisampling method for clearances with values above 170 ml/
/min for ClPl, and for 100 ml/min for ClHp the precision remains
Figure 7. The comparison of precision of plasma clearance determination
by multisample and single sample methods.
Figure 8. The comparison of precision of hepatic clearance determination
by multisample and single sample methods.
constant. For this reason, the simplified method should be used
for scanning and preliminary classification of a patient. However,
for the monitoring of patients' condition, the mutlisample method
should be used.
Conclusions
1. The accuracy of simplified methods for determination of 99mTc-
-HEPIDA clearances is acceptable.
2. Precision of ClPl determination by a simulated method depends
predominantly on its value and ranges from 5% at 250 ml/min
to 20% at low values of the clearance.
3. Precision of ClHp — using a simple method — is somewhat
less satisfactory than that of ClPl and in the range from 100 to
200 ml/min it varies from 17 to 10%.
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